Jonathan Luke McQualter

Jonathan Luke McQualter

Auto-generated profile, based on publicly available information

Jonathan Luke McQualter

School of Health and Biomedical Sciences RMIT University Melbourne Victoria Australia

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
JMJonathan L. McQualter
Jonathan L. McQualter
KYKaren Yuen
Karen Yuen
BWBrenda Williams
Brenda Williams
IBIvan Bertoncello
Ivan Bertoncello
The role of lung epithelial stem cells in maintenance and repair of the adult lung is ill-defined, and their identity remains contentious because of the lack of definitive markers for their prospective isolation and the absence of clonogenic assays able to measure their stem/progenitor cell potential. In this study, we show that replication of epithelial–mesenchymal interactions in a previously undescribed matrigel-based clonogenic assay enables the identification of lung epithelial stem/progenitor cells by their colony-forming potential in vitro. We describe a population of EpCAM hi CD49f pos CD104 pos CD24 low epithelial cfus that generate colonies comprising airway, alveolar, or mixed lung epithelial cell lineages when cocultured with EpCAM neg Sca-1 pos lung mesenchymal cells. We show that soluble fibroblast growth factor-10 and hepatocyte growth factor partially replace the requirement for mesenchymal support of epithelial colony formation, allowing clonal passaging and demonstration of their capacity for self-renewal. These data support a model in which the adult mouse lung contains a minor population of multipotent epithelial stem/progenitor cells with the capacity for self-renewal and whose descendants give rise to airway and alveolar epithelial cell lineages in vitro.

24 September 2001 in Journal of Experimental Medicine
Verified
Journal Article
Closed access
PDF file
JMJonathan L. McQualter
Jonathan L. McQualter
RDRima Darwiche
Rima Darwiche
CEChristine Ewing
Christine Ewing
MOManabu Onuki
Manabu Onuki
TKThomas W. Kay
Thomas W. Kay
CBClaude C.A. Bernard
Claude C.A. Bernard
Experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis, can be induced by immunization with a number of myelin antigens. In particular, myelin oligodendrocyte glycoprotein, a central nervous system (CNS)-specific antigen expressed on the myelin surface, is able to induce a paralytic MS-like disease with extensive CNS inflammation and demyelination in several strains of animals. Although not well understood, the egress of immune cells into the CNS in EAE is governed by a complex interplay between pro and antiinflammatory cytokines and chemokines. The hematopoietic growth factor, granulocyte macrophage colony-stimulating factor (GM-CSF), is considered to play a central role in maintaining chronic inflammation. The present study was designed to investigate the previously unexplored role of GM-CSF in autoimmune-mediated demyelination. GM-CSF−/− mice are resistant to EAE, display decreased antigen-specific proliferation of splenocytes, and fail to sustain immune cell infiltrates in the CNS, thus revealing key activities for GM-CSF in the development of inflammatory demyelinating lesions and control of migration and/or proliferation of leukocytes within the CNS. These results hold implications for the pathogenesis of inflammatory and demyelinating diseases and may provide the basis for more effective therapies for inflammatory diseases, and more specifically for multiple sclerosis.

6 June 2004 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
TKTara Karnezis
Tara Karnezis
WMWim Mandemakers
Wim Mandemakers
JMJonathan L McQualter
Jonathan L McQualter
BZBinhai Zheng
Binhai Zheng
PHPeggy P Ho
Peggy P Ho
CBClaude C A Bernard
Claude C A Bernard

3 January 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SBSteven Bozinovski
Steven Bozinovski
MUMohib Uddin
Mohib Uddin
RVRoss Vlahos
Ross Vlahos
MTMichelle Thompson
Michelle Thompson
JMJonathan L. McQualter
Jonathan L. McQualter
GAGary P. Anderson
Gary P. Anderson
Chronic obstructive pulmonary disease (COPD) will soon be the third most common cause of death globally. Despite smoking cessation, neutrophilic mucosal inflammation persistently damages the airways and fails to protect from recurrent infections. This maladaptive and excess inflammation is also refractory to glucocorticosteroids (GC). Here, we identify serum amyloid A (SAA) as a candidate mediator of GC refractory inflammation in COPD. Extrahepatic SAA was detected locally in COPD bronchoalveolar lavage fluid, which correlated with IL-8 and neutrophil elastase, consistent with neutrophil recruitment and activation. Immunohistochemistry detected SAA was in close proximity to airway epithelium, and in vitro SAA triggered release of IL-8 and other proinflammatory mediators by airway epithelial cells in an ALX/FPR2 (formyl peptide receptor 2) receptor-dependent manner. Lipoxin A4(LXA4) can also interact with ALX/FPR2 receptors and lead to allosteric inhibition of SAA-initiated epithelial responses (pA213 nM). During acute exacerbation, peripheral blood SAA levels increased dramatically and were disproportionately increased relative to LXA4. Human lung macrophages (CD68+) colocalized with SAA and GCs markedly increased SAA in vitro (THP-1, pEC5043 nM). To determine its direct actions, SAA was administered into murine lung, leading to induction of CXC chemokine ligand 1/2 and a neutrophilic response that was inhibited by 15-epi-LXA4but not dexamethasone. Taken together, these findings identify SAA as a therapeutic target for inhibition and implicate SAA as a mediator of GC-resistant lung inflammation that can overwhelm organ protective signaling by lipoxins at ALX/FPR2 receptors.

1 March 2009 in Stem Cells
Verified
Journal Article
Open access
PDF file
JMJonathan L. McQualter
Jonathan L. McQualter
NBNathalie Brouard
Nathalie Brouard
BWBrenda Williams
Brenda Williams
BBBrandi N. Baird
Brandi N. Baird
SSSunder Sims-Lucas
Sunder Sims-Lucas
IBIvan Bertoncello
Ivan Bertoncello
Originally identified as a marker specifying murine hematopoietic stem cells, the Sca-1 antigen has since been shown to be differentially expressed by candidate stem cells in tissues including vascular endothelium, skeletal muscle, mammary gland, and prostate of adult mice. In the adult murine lung, Sca-1 has previously been identified as a selectable marker for the isolation of candidate nonhematopoietic (CD45−), nonendothelial (CD31−) bronchioalveolar stem cells (BASC) located at the bronchioalveolar duct junction that coexpress surfactant protein C and the Clara cell specific protein. Our systematic analysis of CD45−CD31−Sca-1+ cells in fetal, neonatal, and adult lung shows that very few of these cells are detectable prior to birth but expand exponentially postnatally coinciding with the transition from the saccular to the alveolar stage of lung development. Unlike candidate BASCs, the CD45−CD31−Sca-1+CD34+ cell fraction we describe coexpresses immunophenotypic markers (Thy-1 and platelet-derived growth factor receptor α) that define lung fibroblastic rather than epithelial cells. The mesenchymal “signature” of the CD45−CD31−Sca-1+CD34+ cell fraction is further confirmed by transcriptional profiling, by cell culture studies demonstrating enrichment for clonogenic lipofibroblastic and nonlipofibroblastic progenitors, and by immunohistochemical localization of Sca-1 in perivascular cells of the lung parenchyma. Although the CD45−CD31−Sca-1+CD34+ cell phenotype does define endogenous clonogenic progenitor cells in the adult murine lung, our data indicate that these progenitors are predominantly representative of mesenchymal cell lineages, and highlights the pressing need for the identification of alternative markers and robust functional assays for the identification and characterization of epithelial and fibroblastic stem and progenitor cell populations in the adult lung.

1 November 2016 in Stem Cell Reports
Verified
Journal Article
Open access
SRSamriddha Ray
Samriddha Ray
NCNorika Chiba
Norika Chiba
CYChangfu Yao
Changfu Yao
XGXiangrong Guan
Xiangrong Guan
AMAlicia M. McConnell
Alicia M. McConnell
BSBarry R. Stripp
Barry R. Stripp
Recent studies have implicated keratin 5 (KRT5)+ cells in repopulation of damaged lung tissue following severe H1N1 influenza virus infection. However, the origins of the cells repopulating the injured alveolar region remain controversial. We sought to determine the cellular dynamics of lung repair following influenza infection and define whether nascent KRT5+ cells repopulating alveolar epithelium were derived from pre-existing alveolar or airway progenitor cells. We found that the wound-healing response begins with proliferation of SOX2+ SCGB1A1- KRT5- progenitor cells in airways. These cells generate nascent KRT5+ cells as an early response to airway injury and yield progeny that colonize damaged alveolar parenchyma. Moreover, we show that local alveolar progenitors do not contribute to nascent KRT5+ cells after injury. Repopulation of injured airway and alveolar regions leads to proximalization of distal airways by pseudostratified epithelium and of alveoli by airway-derived epithelial cells that lack the normal characteristics of mature airway or alveolar epithelium.